| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | SVP, CFO, CBO & Treasurer | Common Stock | 350K | $441K | $1.26 | Jun 28, 2024 | Direct |
| AVROBIO, Inc. | Interim CEO, President and CFO | Restricted Stock Unit | 120K | $145K | $1.20 | Feb 1, 2024 | Direct |
| AVROBIO, Inc. | Interim CEO, President and CFO | Common Stock | 29.3K | $35.2K | $1.20 | Feb 5, 2024 | Direct |
| Akebia Therapeutics, Inc. | SVP, CFO, CBO & Treasurer | Stock Option (Right to buy) | 500K | Jun 28, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Jun 28, 2024 | 2 | $0 | 4 | Jul 2, 2024 | SVP, CFO, CBO & Treasurer |
| AKBA | Akebia Therapeutics, Inc. | Jun 24, 2024 | 0 | $0 | 3 | Jun 26, 2024 | SVP, CFO, CBO & Treasurer |
| AVRO | AVROBIO, Inc. | Feb 1, 2024 | 3 | -$15.7K | 4 | Feb 5, 2024 | Interim CEO, President and CFO |
| AVRO | AVROBIO, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Interim CEO, President and CFO |
| AVRO | AVROBIO, Inc. | Feb 8, 2023 | 1 | $0 | 4 | Feb 10, 2023 | Chief Financial Officer |
| AVRO | AVROBIO, Inc. | Dec 8, 2022 | 1 | $0 | 4 | Dec 9, 2022 | Chief Financial Officer |
| AVRO | AVROBIO, Inc. | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | Chief Financial Officer |
| AVRO | AVROBIO, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Chief Financial Officer |